Evidence map›Paper›PMID 42100943›Full record

ReviewNanomedicine (London, England)2026

Nanofiber based transformative approaches for tendon regenerative engineering: past, present and future.

Elnaz S Mirdamadi, Debolina Ghosh, Cato T Laurencin

Abstract readReview
In one paragraph

Review in Nanomedicine (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elnaz S MirdamadiThe Cato T. Laurencin Institute for Regenerative Engineering, University of Connecticut, Farmington, CT, USA.
Debolina GhoshThe Cato T. Laurencin Institute for Regenerative Engineering, University of Connecticut, Farmington, CT, USA.
Cato T LaurencinThe Cato T. Laurencin Institute for Regenerative Engineering, University of Connecticut, Farmington, CT, USA.

Funding

Regenerative Engineering of Musculoskeletal Tissues- a Convergence Doctoral Training ProgramT32AR079114 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LAURENCIN, CATO T. · 2021 to 2025
$1.1M
NIAMS NIH HHS T32 AR079114NIAMS NIH HHS T32 AR079114/AR
6 · The paper itself

Abstract

Tendon injuries present a major clinical challenge due to the tissue's limited regenerative capacity, poor vascularization, and tendency toward fibrotic healing that compromises mechanical function. Surgical and conservative treatments often fail to restore native tendon architecture, leading to high rates of retear, adhesion, and long-term functional impairment. In recent years, tissue engineering strategies have gained increasing attention, with nanofiber-based matrices emerging as promising platforms for functional tendon regeneration. Owing to their structural similarity to native extracellular matrix (ECM), nanofiber scaffolds enable precise control over fiber alignment, porosity, and mechanical properties, which are critical for guiding tenogenic cell behavior and matrix organization.This review summarizes recent advances in nanofiber fabrication techniques, including electrospinning and hybrid nanomanufacturing approaches, and discusses strategies for tailoring scaffold properties through biophysiochemical cues, biological factor delivery, cell incorporation, and nanoparticle functionalization. Special emphasis is placed on multifunctional nanofiber systems that modulate inflammation, promote tenogenic differentiation, enhance tendon - bone interface healing, and minimize scar formation and postoperative adhesion. Finally, current challenges and future directions toward scalable manufacturing, reproducibility, and clinical translation are discussed. Collectively, nanofiber-based matrices represent a versatile and powerful approach for advancing tendon tissue engineering and achieving durable functional repair. Search: PubMed, Google Scholar, through March 2026.

Indexed as

NanofibersRegenerationTendon InjuriesTendonsTissue EngineeringAnimalsExtracellular MatrixHumansTissue ScaffoldselectrospinningnanofiberregenerationscaffoldsTendon tissue engineering

Identifiers

PMID42100943
PMCPMC13166232

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.